PolyPid Ltd
Overview
PolyPid Ltd is a biopharmaceutical company dedicated to developing and commercializing novel antibiotic therapies to enhance surgical outcomes. The company's proprietary PLEX technology platform allows for the controlled and prolonged release of medications directly at the target site.
Therapeutic areas
API / Drug Master Files
PolyPid Ltd holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- D-PLEX (DOXYCYCLINE/POLYMER-LIPID ENCAPSULATION MATRIX)Active2026-02-27
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to PolyPid Ltd in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this PolyPid Ltd? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.